Literature DB >> 17261616

Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.

Claudine E Fasching1, Tracy Grossman, Blaise Corthésy, Andrew G Plaut, Jeffrey N Weiser, Edward N Janoff.   

Abstract

Antibodies of the immunoglobulin A (IgA) class react with capsular polysaccharides of Streptococcus pneumoniae and support complement-dependent opsonophagocytosis (OPC) of the organism by phagocytes. We characterized the biologic impact of the molecular forms of human monoclonal capsule-specific IgA (monomeric IgA [mIgA], polymeric IgA [pIgA], and secretory IgA [SIgA]) on OPC and susceptibility to cleavage by IgA1 protease. The efficiency of SIgA in support of OPC of S. pneumoniae was comparable to that of pIgA, and both forms exceeded that of mIgA by a fivefold margin. This structure-function relationship was associated with three factors. First, the avidities, or functional affinities, of both pIgA and SIgA for pneumococcal capsules exceeded those of mIgA. Second, both pIgA and SIgA required less complement to achieve similar levels of bacterial OPC than did mIgA, indicating that secretory component does not hinder the effect of complement. Third, both pIgA and SIgA mediated agglutination of the organism, whereas mIgA did not. All three forms of capsule-specific IgA showed comparable susceptibilities to cleavage and functional inhibition by bacterial IgA1 protease, demonstrating that secretory component does not prevent the proteolytic degradation of IgA1 by IgA1 protease. IgA1 cleavage results in formation of identical Fab fragments for each of the molecular forms, thereby abolishing the contribution of multivalence of pIgA and SIgA. In summary, the polymeric forms of IgA (both pIgA and SIgA) provide a substantial advantage in binding, agglutination, and OPC of the organism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261616      PMCID: PMC1865688          DOI: 10.1128/IAI.01758-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells.

Authors:  J Berdoz; C T Blanc; M Reinhardt; J P Kraehenbuhl; B Corthésy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Activity of human IgG and IgA subclasses in immune defense against Neisseria meningitidis serogroup B.

Authors:  G Vidarsson; W L van Der Pol; J M van Den Elsen; H Vilé; M Jansen; J Duijs; H C Morton; E Boel; M R Daha; B Corthésy; J G van De Winkel
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

3.  In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA.

Authors:  K B Renegar; G D Jackson; J Mestecky
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).

Authors:  B M Gray
Journal:  Pediatrics       Date:  1990-04       Impact factor: 7.124

5.  Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides.

Authors:  S Johnson; N L Opstad; J M Douglas; E N Janoff
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.

Authors:  J A Winkelstein; J A Bocchini; G Schiffman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

7.  A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine.

Authors:  J E Martinez; S Romero-Steiner; T Pilishvili; S Barnard; J Schinsky; D Goldblatt; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

8.  Mouse x human heterohybridomas as fusion partners with human B cell tumors.

Authors:  W L Carroll; K Thielemans; J Dilley; R Levy
Journal:  J Immunol Methods       Date:  1986-05-01       Impact factor: 2.303

9.  Human polymeric IgA is superior to IgG and single-chain Fv of the same monoclonal specificity to inhibit urease activity associated with Helicobacter pylori.

Authors:  José Berdoz; Blaise Corthésy
Journal:  Mol Immunol       Date:  2004-08       Impact factor: 4.407

10.  Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.

Authors:  J O Kim; S Romero-Steiner; U B Sørensen; J Blom; M Carvalho; S Barnard; G Carlone; J N Weiser
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

View more
  22 in total

1.  Septic polyarthritis caused by Streptococcus pneumoniae: primary pneumococcal pneumonia as a risk factor in older patients? A case report.

Authors:  Susanne Habelt; Adrian Schwaller; Albert Hollinger; Ladislav Mica
Journal:  BMJ Case Rep       Date:  2009-12-03

2.  Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.

Authors:  Ellen L Burnham; Jeanette Gaydos; Edward Hess; Robert House; Jacinta Cooper
Journal:  Alcohol Alcohol       Date:  2010-08-20       Impact factor: 2.826

3.  Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.

Authors:  Kevin Fabrizio; Catherine Manix; Allan J Guimaraes; Joshua D Nosanchuk; Liise-Anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

Review 4.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Genome-wide association study identifies TNFSF13 as a susceptibility gene for IgA in a South Chinese population in smokers.

Authors:  Chen Yang; Wang Jie; Yang Yanlong; Guo Xuefeng; Tan Aihua; Gao Yong; Lu Zheng; Zhang Youjie; Zhang Haiying; Qin Xue; Qin Min; Mo Linjian; Yang Xiaobo; Hu Yanling; Mo Zengnan
Journal:  Immunogenetics       Date:  2012-08-03       Impact factor: 2.846

6.  Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1.

Authors:  Ulrike Binsker; John A Lees; Alexandria J Hammond; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

7.  Agglutination of Histoplasma capsulatum by IgG monoclonal antibodies against Hsp60 impacts macrophage effector functions.

Authors:  Allan Jefferson Guimarães; Susana Frases; Bruno Pontes; Mariana Duarte de Cerqueira; Marcio L Rodrigues; Nathan Bessa Viana; Leonardo Nimrichter; Joshua Daniel Nosanchuk
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

8.  A Capsular Polysaccharide-Specific Antibody Alters Streptococcus pneumoniae Gene Expression during Nasopharyngeal Colonization of Mice.

Authors:  Christopher R Doyle; Jee-Young Moon; Johanna P Daily; Tao Wang; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 9.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

10.  Novel Monoclonal Antibodies for Studies of Human and Rhesus Macaque Secretory Component and Human J-Chain.

Authors:  Ruijun Zhang; S Munir Alam; Jae-Sung Yu; Richard Scearce; Bradley Lockwood; Kwan-Ki Hwang; Robert Parks; Sallie Permar; Per Brandtzaeg; Barton F Haynes; Hua-Xin Liao
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.